Gnomon Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Thane, Maharashtra, India, established in 2019.
2019 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Gnomon Pharmaceuticals Private Limited

Gnomon Pharmaceuticals Private Limited, a active private limited company, was established on 20 December 2019 in Thane, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100MH2019PTC334805. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹10.00 K .

Its leadership includes Milind Bhalekar (Director), Aesha Dilip Shah (Director), Kiran Sopan More (Director). It is based at 'Princeton' A'Wing Ft.N.1203 Patlipada G.B.Road, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2019PTC334805

  • Registration Number

    334805

  • Incorporation Date

    20 December 2019

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹10.00 K

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 6 Year, 5 Months
Company report

Gnomon Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Gnomon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gnomon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Milind Bhalekar Director 20 Dec 2019 Current
Aesha Dilip Shah Director 20 Dec 2019 Current
Kiran Sopan More Director 20 Dec 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gnomon Pharmaceuticals.

Enhance accessibility to Gnomon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gnomon Pharmaceuticals revenue growth over time
Gnomon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gnomon Pharmaceuticals?

Unlock access to Gnomon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gnomon Pharmaceuticals?

Unlock and access historical data on people associated with Gnomon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gnomon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnomon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gnomon Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Milind Bhalekar was appointed as a Director was appointed as a Director on 20 Dec 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Director Appointment

    Aesha Dilip Shah was appointed as a Director was appointed as a Director on 20 Dec 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Director Appointment

    Kiran Sopan More was appointed as a Director was appointed as a Director on 20 Dec 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Gnomon Pharmaceuticals Private Limited was registered on 20 Dec 2019 with Roc Mumbai & aged 6 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gnomon Pharmaceuticals Private Limited?

The CIN of Gnomon Pharmaceuticals Private Limited is U24100MH2019PTC334805.

Where is Gnomon Pharmaceuticals Private Limited headquartered?

Gnomon Pharmaceuticals Private Limited is headquartered at 'Princeton' A'Wing Ft.N.1203 Patlipada G.B.Road, Thane, Maharashtra, 400607.

When was Gnomon Pharmaceuticals Private Limited incorporated?

Gnomon Pharmaceuticals Private Limited was incorporated on 20 December 2019.

Who are the current directors of Gnomon Pharmaceuticals Private Limited?

The current directors of Gnomon Pharmaceuticals Private Limited are

What is the primary industry of Gnomon Pharmaceuticals Private Limited?

The primary industry of Gnomon Pharmaceuticals Private Limited is Chemicals.

Is Gnomon Pharmaceuticals Private Limited a listed company?

Gnomon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Gnomon Pharmaceuticals Private Limited?

The authorized capital of Gnomon Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹10.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available